Bimi International Medical Inc (NASDAQ:BIMI) — Market Cap & Net Worth
Market Cap & Net Worth: Bimi International Medical Inc (BIMI)
Bimi International Medical Inc (NASDAQ:BIMI) has a market capitalization of $1.40K ($1.40K) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31399 globally and #6028 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bimi International Medical Inc's stock price $0.00 by its total outstanding shares 13960740 (13.96 Million). Analyse BIMI cash flow metrics to see how efficiently the company converts income to cash.
Bimi International Medical Inc Market Cap History: 2025 to 2026
Bimi International Medical Inc's market capitalization history from 2025 to 2026. Data shows growth from $1.40K to $1.40K (0.00% CAGR).
Bimi International Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bimi International Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BIMI by Market Capitalization
Companies near Bimi International Medical Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Bimi International Medical Inc by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1408 globally with a market cap of $17.90 Billion USD ( €15.31 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2179 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2534 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #2723 globally with a market cap of $7.53 Billion USD ( R$38.36 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1408 | JD HEALTH INTL LTD | F:8ZN | $17.90 Billion | €4.90 |
| #2179 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2534 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #2723 | Raia Drogasil S.A | SA:RADL3 | $7.53 Billion | R$21.94 |
Bimi International Medical Inc Historical Marketcap From 2025 to 2026
Between 2025 and today, Bimi International Medical Inc's market cap moved from $1.40K to $ 1.40K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.40K | 0.00% |
| 2025 | $1.40K | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Bimi International Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.40K USD |
| MoneyControl | $1.40K USD |
| MarketWatch | $1.40K USD |
| marketcap.company | $1.40K USD |
| Reuters | $1.40K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bimi International Medical Inc
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescr… Read more